TEZSPIRE is an add-on medication to treat patients 12 and older with severe asthma and adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Learn more about TEZSPIRE …

Oct 20, 2025 · Tezspire (tezepelumab-ekko) is used in adults and adolescents 12 years and older for the maintenance treatment of severe asthma in those whose asthma is not controlled with …

TEZSPIRE® (tezepelumab-ekko), add-on maintenance treatment for severe asthma and CRSwNP, is the first and only biologic approved to target TSLP and help address epithelial …

Aug 1, 2024 · Find patient medical information for Tezspire (tezepelumab-ekko) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged …

Your healthcare provider will give you TEZSPIRE in a healthcare setting. TEZSPIRE is injected under your skin (subcutaneously) 1 time every 4 weeks. If you miss an appointment, ask your …

Oct 17, 2025 · 1.1 Asthma - TEZSPIRE is indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma. Limitations of Use: …

Dec 1, 2025 · Tezepelumab-ekko injection is used together with other medicines as maintenance treatment for severe asthma. Tezepelumab-ekko helps prevent severe asthma attacks …

Dosage Form Description Tezspire (tezepelumab injection) is a sterile, preservative-free solution intended for subcutaneous injection.

Medscape - Severe asthma dosing for Tezspire (tezepelumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …